arrow
J

Judd F. Hultquist

northwestern university
H指数:41
被引数:6,346

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Repurposing drug screen for the identification of helicase inhibitors from viruses of pandemic concern

用于识别来自流行病相关病毒解旋酶抑制剂的药物重用筛选

2026-04-290
OAAI
Integrative Multi-Omics Analysis In Vivo Identifies Influenza A Virus Host Factors

整合多组学活体分析鉴定出甲型流感病毒宿主因子

2025-09-240
OAAI
CACHE Challenge #2: Targeting the RNA Site of the SARS-CoV-2 Helicase Nsp13

CACHE挑战赛#2:靶向SARS-CoV-2解旋酶Nsp13的RNA位点

2025-06-200
PRE
The ability of SAMHD1-deficient monocytes to trigger the type I IFN response depends on cGAS and mitochondrial DNA

SAMHD1缺陷型单核细胞触发I型干扰素反应的能力依赖于cGAS和线粒体DNA。

2025-06-010
OA
Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus MPro inhibitors with potent in vivo efficacy

基于结构的具有高生物利用度、共价键、广谱冠状病毒MPro抑制剂的发现,并具有强体内效力

2025-04-250
OA
CPSF6 promotes HIV-1 preintegration complex function
2025-04-010
OAAI
Distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia

肺泡T细胞反应的独特演变与未接种疫苗的SARS-CoV-2肺炎患者的临床结局相关

2024-08-132
PRE
Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus
Nature
IF48.5
2024-07-100
PRE
CRISPR-Cas9 screen of E3 ubiquitin ligases identifies TRAF2 and UHRF1 as regulators of HIV latency in primary human T cells

E3泛素连接酶的CRISPR-Cas9筛选将TRAF2和UHRF1鉴定为原代人T细胞中HIV潜伏期的调节剂

MBIO
IF4.7
2024-04-100
OAAI